Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare Inc. (Nasdaq: IXHL) is back on traders’ radar after the U.S. Food and Drug Administration granted Fast Track designation to its lead sleep-apnoea drug candidate, IHL‑42X. The move caps a busy 2025 that also brought strong Phase 2 data in sleep apnoea and psilocybin-assisted therapy, a major clean-up of warrant overhang, and a fight to keep the company’s Nasdaq listing alive. SEC+1 As of the U.S. session on 4 December 2025, IXHL was trading around $0.48 per share, up roughly 8% on the day and extending a sharp two-day rebound following the Fast Track news. ChartMill Below is
4 December 2025
·
KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

As of December 4, 2025, KALA BIO, Inc. (NASDAQ: KALA) has turned into one of the wildest tickers on the Nasdaq. The stock is trading around $1.40 in heavy volume, up roughly 50% on the day after a cascade of news: a $10 million registered direct offering, a loan settlement that turns lender Oxford Finance into a 16.5% shareholder, and a $6 million rescue-style preferred investment from new CEO David Lazar. All this arrives barely two months after KALA’s lead drug failed a key trial, its lender swept most of its cash, and management warned of “substantial doubt” about its
4 December 2025
·
Applied Materials (AMAT) Stock Near Record Highs as TD Cowen Sets $315 Target and Analysts Double Down on AI, DRAM and TSMC Upside

Applied Materials (AMAT) Stock Near Record Highs as TD Cowen Sets $315 Target and Analysts Double Down on AI, DRAM and TSMC Upside

Applied Materials is ending 2025 with the kind of momentum most semiconductor names can only envy. The chip-equipment giant’s shares are trading around all‑time highs in the high‑$260s/low‑$270s, up roughly 60% year‑to‑date after a powerful seven‑session winning streak. Seeking Alpha+2Morningstar+2 On December 4, 2025, a fresh wave of bullish research — led by TD Cowen’s new $315 price target and a “best idea for 2026” label — crystallized a narrative that has been building for months: Applied Materials (NASDAQ: AMAT) is becoming a pure‑play way to bet on the next leg of AI, DRAM and advanced foundry spending. Investing.com+2MarketBeat+2 At
4 December 2025
···
Regeneron (REGN) Price Target Hits $1,057 as BMO and Canaccord Lift Forecasts on Dupixent Growth

Regeneron (REGN) Price Target Hits $1,057 as BMO and Canaccord Lift Forecasts on Dupixent Growth

Published: December 4, 2025 Key Takeaways Wall Street Re‑rates Regeneron After Big Run — and Bigger Dupixent Story Regeneron Pharmaceuticals has suddenly become one of the most hotly debated large‑cap biotechs on Wall Street. On Thursday, December 4, 2025, multiple analyst moves and fresh data reshaped the Regeneron (REGN) stock narrative: Taken together, these moves signal that, despite a sharp rally off the summer lows, many professionals still see upside in REGN stock, driven primarily by Dupixent, Regeneron’s blockbuster anti‑inflammatory drug co‑developed with Sanofi, and a deepening pipeline in genetics and oncology. Investing.com+1 At the same time, concerns about valuation
4 December 2025
·
Costco Stock (COST) in December 2025: Tariff Fight, Strong Sales and a High‑Valuation 2026 Buy Case

Costco Stock (COST) in December 2025: Tariff Fight, Strong Sales and a High‑Valuation 2026 Buy Case

Costco stock sits at an odd crossroads as of December 4, 2025. Operationally, the warehouse giant is firing on almost all cylinders: sales are growing, e‑commerce is accelerating, and membership income keeps hitting records. At the same time, the company is suing the Trump administration over tariffs, analysts are debating whether its premium valuation still has room to run, and the stock itself is roughly flat this year while the S&P 500 has surged. Costco Investor Relations+2Finviz+2 With fresh data and commentary arriving this week – including new sales numbers, analyst upgrades, and legal developments – investors are asking a
4 December 2025
Tonix Pharmaceuticals (TNXP) Stock Today, December 4, 2025: Tonmya Launch, Buyback and $400M ATM Define a Volatile Biotech Story

Tonix Pharmaceuticals (TNXP) Stock Today, December 4, 2025: Tonmya Launch, Buyback and $400M ATM Define a Volatile Biotech Story

As Tonix Pharmaceuticals transitions from clinical-stage hopeful to commercial biotech on the back of its new fibromyalgia drug Tonmya, Wall Street is split between blockbuster dreams and dilution fears. TNXP Stock on December 4, 2025: Price, Volume and Volatility Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) spent Thursday, December 4, 2025 trading around the high‑teens, with several data providers showing the stock near $19–20 per share during U.S. hours. MarketBeat cites a real‑time price of about $19.98, while CoinCodex shows $19.66, both up roughly 10–12% on the day. MarketBeat+1 That price puts Tonix’s market capitalization near $190 million, a tiny cap
4 December 2025
··
Roku Stock (ROKU) on December 4, 2025: Guggenheim Upgrade, Insider Moves and 2026 Outlook

Roku Stock (ROKU) on December 4, 2025: Guggenheim Upgrade, Insider Moves and 2026 Outlook

Roku, Inc. (NASDAQ: ROKU) is heading into the crucial holiday quarter with its share price pulling back from recent highs, even as Wall Street raises price targets and fresh data confirms an improving profitability and connected‑TV (CTV) ad story. On Thursday, December 4, 2025, Guggenheim lifted its price target on Roku to $115 and reiterated a Buy rating, citing stronger‑than‑expected growth drivers into 2026 and rising CTV ad demand.Investing.com At the same time, new insider and institutional filings, robust third‑quarter results, and a growing web of ad‑tech and smart‑TV partnerships are reshaping the risk–reward profile for Roku stock. Below is
4 December 2025
UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts and 2026 Outlook as of December 4, 2025

UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts and 2026 Outlook as of December 4, 2025

UnitedHealth Group Incorporated (NYSE: UNH) is back under intense scrutiny from Wall Street and regulators after one of the most turbulent stretches in its history. As of Thursday, December 4, 2025, UNH stock is trading around $333–340 per share, giving the company a market capitalization just over $300 billion and leaving the shares more than 45% below their 12‑month high near $623. MarketBeat+1 The past year has brought a catastrophic cyberattack, a criminal and civil investigation by the U.S. Department of Justice (DOJ), a leadership shake‑up that saw longtime executive Stephen Hemsley return as CEO, and the shocking killing of
4 December 2025
·
Archer Aviation (ACHR) Stock Today: Miami Air Taxi Network, Defense Deals and New Ratings – What December 4, 2025 Means for Investors

Archer Aviation (ACHR) Stock Today: Miami Air Taxi Network, Defense Deals and New Ratings – What December 4, 2025 Means for Investors

Archer Aviation Inc. (NYSE: ACHR) is back in the spotlight after a flurry of December headlines – from an ambitious air‑taxi network in Miami to deeper defense and Middle East partnerships, a major airport acquisition in Los Angeles, and fresh institutional buying. On December 4, 2025, Archer’s stock was trading around $8.4 per share, up modestly on the day and well off its 52‑week high near $14.6. That gives the company a market capitalisation in the neighborhood of $6 billion, with a 52‑week range of roughly $5.48 to $14.62 and a high beta of about 3.1, underlining its volatility. StockAnalysis
4 December 2025
··
Five Below (FIVE) Stock Jumps on Q3 2025 Earnings Beat: Fresh Price Targets, Forecasts and Risks for Investors

Five Below (FIVE) Stock Jumps on Q3 2025 Earnings Beat: Fresh Price Targets, Forecasts and Risks for Investors

As of December 4, 2025, Five Below, Inc. (NASDAQ: FIVE) is trading around $160–$165 per share, after a powerful rally that has pushed the discount retailer roughly 60% higher in 2025 and more than tripled the stock from its April lows near $52.StockAnalysis+3StockAnalysis+3INDmoney+3 The latest surge comes on the heels of strong Q3 fiscal 2025 results released on December 3: revenue grew more than 23%, comparable‑store sales jumped in the mid‑teens, and management raised full‑year guidance for both sales and earnings.Five Below Investor+2Licensing International+2 Wall Street has reacted quickly. Jefferies lifted its price target on Five Below to $215 and
4 December 2025
··
ON Semiconductor (NASDAQ: ON) Stock Outlook for December 2025: AI Power, $6 Billion Buyback and SiC Mega-Fab Fuel the Next Leg

ON Semiconductor (NASDAQ: ON) Stock Outlook for December 2025: AI Power, $6 Billion Buyback and SiC Mega-Fab Fuel the Next Leg

ON Semiconductor Corporation – now branding itself as onsemi – has had a wild 2025. After a bruising cyclical downturn and an electric-vehicle hangover, the stock has snapped back sharply into December as investors refocus on AI data centers and advanced power chips. As of the afternoon of December 4, 2025, ON trades around $56 per share, giving the company a roughly $20–21 billion market cap, with a 52‑week range of about $31 to $71 and a trailing P/E near 69 but a forward P/E closer to the high teens. Wealthyhood Below is a deep dive into the latest numbers,
4 December 2025
···
BlackRock (BLK) Stock on 4 December 2025: New Income ETF, Infrastructure Pivot and AI-Driven 2026 Outlook

BlackRock (BLK) Stock on 4 December 2025: New Income ETF, Infrastructure Pivot and AI-Driven 2026 Outlook

BlackRock, Inc. (NYSE: BLK) is trading around $1,080 per share on 4 December 2025, valuing the world’s largest asset manager at roughly $175–176 billion. The stock sits in the middle of its 52‑week range of $773.74–$1,219.94, with a trailing P/E near 28 and a forward P/E just above 20, and it currently offers an annual dividend of $20.84 per share (≈1.9% yield). StockAnalysis Fresh news around BlackRock spans a new income‑focused ETF launch, a pause in plans for a European infrastructure fund, a high‑conviction 2026 macro outlook built around AI, and mixed signals from crypto ETF flows and technical models.
4 December 2025
···
Kroger (KR) Stock on December 4, 2025: Q3 Earnings, Guidance Shift and Mixed Forecasts Explained

Kroger (KR) Stock on December 4, 2025: Q3 Earnings, Guidance Shift and Mixed Forecasts Explained

Kroger’s latest earnings report turned into a full‑on stress test for its stock. On December 4, 2025, The Kroger Co. (NYSE: KR) reported fiscal Q3 2025 results, took a multibillion‑dollar impairment charge on its automated fulfillment network, raised the lower end of its full‑year earnings outlook – and watched its shares sell off sharply anyway. PR Newswire+1 Around mid‑session, KR was trading close to $62 per share, down roughly 6% on the day, after having closed above $67 on December 3. Real‑time market data from several platforms showed intraday quotes between about $61.98 and $62.62, corresponding to a decline of
4 December 2025
··
Australia’s October 2025 Trade Surplus Widens to A$4.39 Billion as Gold and Commodities Drive Mixed Export Story

Australia’s October 2025 Trade Surplus Widens to A$4.39 Billion as Gold and Commodities Drive Mixed Export Story

Australia’s export engine delivered a solid, if not spectacular, performance at the start of Q4, with fresh data for October 2025 showing a wider goods trade surplus, strong non‑monetary gold flows and resilient consumer‑related imports – all against the backdrop of booming household spending and rising interest‑rate expectations. Headline numbers: surplus widens as Q4 trade gets underway On Thursday, 4 December 2025, the Australian Bureau of Statistics (ABS) reported that the seasonally adjusted balance on goods (merchandise trade only) rose to a surplus of A$4.385 billion in October, up from a revised A$3.707 billion in September. Australian Bureau of Statistics
4 December 2025
Surf Air Mobility (SRFM) Stock Today: Price, Palantir Partnership, Q3 Results and 2026 Forecasts – 4 December 2025

Surf Air Mobility (SRFM) Stock Today: Price, Palantir Partnership, Q3 Results and 2026 Forecasts – 4 December 2025

Surf Air Mobility Inc. (NYSE: SRFM) remains one of the loudest penny stocks in the regional aviation niche — and one of the riskiest. On 4 December 2025, the stock is trading sharply higher intraday while fresh Q3 results, new financing deals and aggressive Wall Street price targets collide with a very real going‑concern warning and heavy dilution risk.Stock Titan+1 Below is a structured look at the latest price action, news, forecasts and analyses as of 4 December 2025. SRFM stock price on 4 December 2025 As of the latest trading data on 4 December 2025, Surf Air Mobility shares
4 December 2025
··
MrBeast Financial, Beast Mobile and a Fan-Focused IPO: How Jimmy Donaldson Is Turning His YouTube Empire Into a Fintech Powerhouse

MrBeast Financial, Beast Mobile and a Fan-Focused IPO: How Jimmy Donaldson Is Turning His YouTube Empire Into a Fintech Powerhouse

MrBeast is no longer just giving away cars and islands on YouTube – he’s quietly building something that looks a lot like a modern consumer conglomerate. At The New York Times’ DealBook Summit on December 3, 2025, Beast Industries CEO Jeffrey Housenbold confirmed that the company is preparing a financial services platform branded “MrBeast Financial” and a new mobile phone service called Beast Mobile, both aimed squarely at the creator’s hundreds of millions of fans.Business Insider+1 At the same time, Housenbold is openly toying with the idea of a future IPO that would let fans buy into the business, turning
4 December 2025
·
Bristol Myers Squibb (BMY) Stock Today: Cobenfy Trial Twist, AI Drug Discovery Milestone and $6.7 Billion Lawsuit Shape the 2026 Outlook

Bristol Myers Squibb (BMY) Stock Today: Cobenfy Trial Twist, AI Drug Discovery Milestone and $6.7 Billion Lawsuit Shape the 2026 Outlook

As of December 4, 2025, Bristol Myers Squibb Company (NYSE: BMY) is back on the radar of growth, value and dividend investors. After a sharp rally this week driven by fresh news on its Alzheimer’s drug Cobenfy, an AI-enabled drug discovery milestone and a high‑stakes lawsuit ruling, BMY stock is trading around $50.55, giving the U.S. pharma giant a market capitalization of roughly $104 billion.MarketBeat At the same time, investors are weighing a near‑5% dividend yield, looming patent cliffs for Eliquis and Opdivo, and a newly revived $6.7 billion Celgene CVR lawsuit.Business Wire+2Reuters+2 This article rounds up the latest Bristol
4 December 2025
··
GameStop Corp. WT (GME.WS / GME‑WT) Warrants in Focus: Price Today, December 2025 Outlook and Key Risks

GameStop Corp. WT (GME.WS / GME‑WT) Warrants in Focus: Price Today, December 2025 Outlook and Key Risks

GameStop has a new favorite ticker for speculators to obsess over — and this time it isn’t just GME. Following a warrant dividend this autumn, GameStop Corp. WT (trading on the NYSE as GME.WS, and shown on some platforms as GME‑WT or GameStop Corp. WT EXP 10/30/26) has become a highly leveraged way to bet on the company’s next act. As of December 4, 2025, the warrants are rallying alongside the underlying stock ahead of a closely watched earnings report and a headline‑friendly promotion dubbed “Trade Anything Day.” Benzinga+1 Below is a detailed look at how the warrants work, how
4 December 2025
·
CIBC Stock Today (CM): Q4 2025 Earnings Beat, Dividend Hike and 2026 Outlook

CIBC Stock Today (CM): Q4 2025 Earnings Beat, Dividend Hike and 2026 Outlook

Toronto — December 4, 2025 Canadian Imperial Bank of Commerce (CIBC, TSX: CM; NYSE: CM) is ending 2025 on a high note. The bank has delivered record fourth‑quarter and full‑year results, raised its dividend, announced fresh leadership moves for 2026 and pushed its stock close to all‑time highs — even as it sets aside more money for potential loan losses. Media Centre+2Mortgage Professional Australia+2 For investors watching Canadian bank stocks, CM has suddenly become one of the most interesting names heading into 2026. CIBC stock near 52‑week highs on TSX and NYSE CIBC shares are trading close to their best
4 December 2025
···
Bank of Montreal (BMO) Stock: Q4 2025 Earnings Beat, Dividend Hike and What It Means for 2026

Bank of Montreal (BMO) Stock: Q4 2025 Earnings Beat, Dividend Hike and What It Means for 2026

Bank of Montreal stock is finishing 2025 in the spotlight. The 208‑year‑old bank has just reported strong fiscal 2025 results, raised its dividend again, launched new real‑time payment APIs, and attracted fresh analyst scrutiny as Canadian bank valuations stretch above long‑term averages.BMO Newsroom+2Finviz+2 Here’s a deep dive into the latest news, numbers, and forecasts around Bank of Montreal (TSX: BMO, NYSE: BMO) as of December 4, 2025. Where BMO stock trades today Dual‑listed shares near multi‑year highs BMO’s own filings show a closing TSX share price of C$174.23 at its October 31 fiscal year‑end, up from C$126.88 a year earlier
4 December 2025
···
1 … 484 485 486 487 488 … 535

Stock Market Today

Kweichow Moutai (600519) stock price slides 2.6% — what to know before China markets reopen

Kweichow Moutai (600519) stock price slides 2.6% — what to know before China markets reopen

7 February 2026
SHANGHAI, Feb 8, 2026, 04:42 (CST) — Market closed. Kweichow Moutai Co., Ltd. Class A shares (600519.SS) last closed at 1,515.01 yuan, down 2.57% on Friday, trimming a strong start to February ahead of the new week. The stock traded about 7.9 million shares and roughly 12.0 billion yuan in turnover, and it remains up around 6% over the past month and about 10% for the year to date. (AAStocks) Mainland markets are shut for the weekend and reopen on Monday. Moutai’s moves tend to echo beyond one stock: it is a heavyweight consumer name and a key proxy for
China Construction Bank Class A stock ticks up at Friday close as China data looms

China Construction Bank Class A stock ticks up at Friday close as China data looms

7 February 2026
China Construction Bank Class A shares closed up 0.11% at 8.84 yuan in Shanghai on Friday, with around 100 million shares traded. The Shanghai Composite slipped 0.25%. Investors are watching for January inflation data on Feb. 11 and credit figures on Feb. 13 for policy signals. Premier Li Qiang called for early fiscal support to meet economic targets, state media reported.
PetroChina Class A stock rises with oil rebound — what 601857 traders watch next week

PetroChina Class A stock rises with oil rebound — what 601857 traders watch next week

7 February 2026
PetroChina A-shares rose 2.3% to 10.77 yuan Friday, outperforming the Shanghai Composite, which fell 0.25%. Crude prices rebounded, with Brent settling at $68.05 a barrel, as traders tracked U.S.-Iran talks and new EU sanctions proposals. About 198.5 million PetroChina shares traded in the session. Investors await the company’s next earnings report later this quarter.
Morgan Stanley stock price bounces after three-day slide; what to watch before Monday

Morgan Stanley stock price bounces after three-day slide; what to watch before Monday

7 February 2026
Morgan Stanley shares rose 2.34% to $179.96 Friday, snapping a three-day slide as the Dow closed above 50,000 for the first time. About 9.1 million MS shares traded hands. The rebound followed Thursday’s 2.35% drop and came amid renewed rate-cut speculation and surging AI spending. Morgan Stanley remains 6.6% below its January high.
Go toTop